Skip to main content

Dr. Wilfried Hauke

Associated Partner


Dr. Wilfried Hauke is a physician by training specialized in pharmaceutical medicine. With more than 30 years working in various fields of the pharmaceutical industry Wilfried gained outstanding experience in drug development and regulatory strategies, allowing a holistic view on relevant processes within pharmaceutical companies. He exhibits a wide range of competences in management and consulting starting his career at Hoechst AG, Frankfurt where he was involved in the clinical development of anti-infective, gastrointestinal, oncology and cardiovascular drugs and at Roussel UCLAF, Paris in international medical marketing. As CEO, Chief Medical Officer and Board Member of various CRO/Biotech companies he was responsible for company performance, development strategy and change management processes. More recently Wilfried took over responsibility as CMO for Trophos, Marseille, acquired by Roche in 2015 and Cardior, Hannover.

Throughout his career he successfully set focus in risk-benefit-analysis and successfully completed numerous due diligence projects supporting seller and purchaser perspective. He built up a strong network of research specialists as well as high ranking industrial partners and investors.